Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China · Delayed Price · Currency is CNY 23.75
+0.13 (0.55%)
Jun 11, 2026, 9:59 AM CST
SHA:688566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 254.07 | 261.61 | 219.33 | 219.09 | 154.67 | 114.9 |
Depreciation & Amortization | 17.71 | 17.71 | 10.7 | 11.2 | 12.75 | 12.98 |
Other Amortization | 0.75 | 0.75 | 0.8 | 1.07 | 1.09 | 1.09 |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.01 | - |
Loss (Gain) From Sale of Investments | 0.81 | 0.81 | 40.85 | 0.48 | -5.68 | -17.26 |
Provision & Write-off of Bad Debts | -2.62 | -2.62 | 2.26 | 7.2 | 0.73 | -1.77 |
Other Operating Activities | -60.1 | -1.67 | -0.59 | 1.81 | -0.4 | -0.55 |
Change in Accounts Receivable | -61 | -61 | -24.28 | -138.14 | -72.08 | 42.96 |
Change in Inventory | 3.61 | 3.61 | -1.19 | 1.12 | -0.83 | 0.28 |
Change in Accounts Payable | 11.58 | 11.58 | -37.6 | 38.47 | 39.43 | -8.6 |
Change in Other Net Operating Assets | 23.03 | 23.03 | 6.81 | 17.89 | 21.51 | 7.33 |
Operating Cash Flow | 182.34 | 248.3 | 215.29 | 159.5 | 150.72 | 150.56 |
Operating Cash Flow Growth | 2.79% | 15.33% | 34.98% | 5.82% | 0.11% | 28.28% |
Capital Expenditures | -111.35 | -114.6 | -174.53 | -357.37 | -292.7 | -83.79 |
Sale of Property, Plant & Equipment | 0 | 0 | - | - | 0.01 | 0 |
Cash Acquisitions | -20.38 | -20.38 | - | - | - | - |
Investment in Securities | -137.6 | -142.6 | -51 | -15 | 108.8 | -270 |
Other Investing Activities | 200.4 | 3 | 5.36 | 8.33 | 8.41 | 20.64 |
Investing Cash Flow | -68.92 | -274.57 | -220.17 | -364.04 | -175.49 | -333.15 |
Short-Term Debt Issued | - | 63.85 | 39.26 | 19.74 | - | - |
Total Debt Issued | 63.85 | 63.85 | 39.26 | 19.74 | - | - |
Total Debt Repaid | -2.2 | - | - | - | - | - |
Net Debt Issued (Repaid) | 61.65 | 63.85 | 39.26 | 19.74 | - | - |
Issuance of Common Stock | - | - | 222.29 | 24.29 | - | - |
Common Dividends Paid | -103.71 | -103.7 | -102.95 | -44.87 | -89.73 | -89.73 |
Other Financing Activities | -11.26 | - | -1.31 | -0.4 | - | - |
Financing Cash Flow | -53.32 | -39.86 | 157.3 | -1.23 | -89.73 | -89.73 |
Net Cash Flow | 60.1 | -66.13 | 152.42 | -205.77 | -114.5 | -272.32 |
Free Cash Flow | 70.99 | 133.71 | 40.76 | -197.87 | -141.98 | 66.77 |
Free Cash Flow Growth | 306.03% | 228.01% | - | - | - | -28.73% |
Free Cash Flow Margin | 7.17% | 13.84% | 4.55% | -22.98% | -21.68% | 13.10% |
Free Cash Flow Per Share | 0.35 | 0.67 | 0.21 | -1.06 | -0.76 | 0.35 |
Cash Income Tax Paid | 167.44 | 152.97 | 141.42 | 93.83 | 83.36 | 83.52 |
Levered Free Cash Flow | -21.29 | 75.19 | -10.03 | -303.05 | -187.73 | 85.4 |
Unlevered Free Cash Flow | -21.16 | 75.36 | -9.95 | -302.99 | -187.5 | 85.4 |
Change in Working Capital | -28.28 | -28.28 | -58.05 | -81.35 | -12.44 | 41.18 |